TrialJournal of clinical psychopharmacology

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104: A Double-Blind, Randomized, Single Ascending Dose Placebo-Controlled Study.

Guy Ludbrook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.